Cargando…
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168487/ https://www.ncbi.nlm.nih.gov/pubmed/33299234 http://dx.doi.org/10.3324/haematol.2020.260133 |
| _version_ | 1783701887013355520 |
|---|---|
| author | Lesieur, Auriane Thomas, Xavier Nibourel, Olivier Boissel, Nicolas Fenwarth, Laurène De Botton, Stéphane Fournier, Elise Celli-Lebras, Karine Raffoux, Emmanuel Recher, Christian Lambert, Juliette Berthon, Céline Pigneux, Arnaud Itzykson, Raphael Turlure, Pascal Pautas, Cécile Vargaftig, Jacques Preudhomme, Claude Dombret, Hervé Duployez, Nicolas |
| author_facet | Lesieur, Auriane Thomas, Xavier Nibourel, Olivier Boissel, Nicolas Fenwarth, Laurène De Botton, Stéphane Fournier, Elise Celli-Lebras, Karine Raffoux, Emmanuel Recher, Christian Lambert, Juliette Berthon, Céline Pigneux, Arnaud Itzykson, Raphael Turlure, Pascal Pautas, Cécile Vargaftig, Jacques Preudhomme, Claude Dombret, Hervé Duployez, Nicolas |
| author_sort | Lesieur, Auriane |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8168487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81684872021-06-11 Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use Lesieur, Auriane Thomas, Xavier Nibourel, Olivier Boissel, Nicolas Fenwarth, Laurène De Botton, Stéphane Fournier, Elise Celli-Lebras, Karine Raffoux, Emmanuel Recher, Christian Lambert, Juliette Berthon, Céline Pigneux, Arnaud Itzykson, Raphael Turlure, Pascal Pautas, Cécile Vargaftig, Jacques Preudhomme, Claude Dombret, Hervé Duployez, Nicolas Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-12-10 /pmc/articles/PMC8168487/ /pubmed/33299234 http://dx.doi.org/10.3324/haematol.2020.260133 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Lesieur, Auriane Thomas, Xavier Nibourel, Olivier Boissel, Nicolas Fenwarth, Laurène De Botton, Stéphane Fournier, Elise Celli-Lebras, Karine Raffoux, Emmanuel Recher, Christian Lambert, Juliette Berthon, Céline Pigneux, Arnaud Itzykson, Raphael Turlure, Pascal Pautas, Cécile Vargaftig, Jacques Preudhomme, Claude Dombret, Hervé Duployez, Nicolas Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| title | Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| title_full | Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| title_fullStr | Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| title_full_unstemmed | Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| title_short | Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| title_sort | minimal residual disease monitoring in acute myeloid leukemia with non-a/b/d npm1 mutations by digital polymerase chain reaction: feasibility and clinical use |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168487/ https://www.ncbi.nlm.nih.gov/pubmed/33299234 http://dx.doi.org/10.3324/haematol.2020.260133 |
| work_keys_str_mv | AT lesieurauriane minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT thomasxavier minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT nibourelolivier minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT boisselnicolas minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT fenwarthlaurene minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT debottonstephane minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT fournierelise minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT cellilebraskarine minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT raffouxemmanuel minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT recherchristian minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT lambertjuliette minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT berthonceline minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT pigneuxarnaud minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT itzyksonraphael minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT turlurepascal minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT pautascecile minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT vargaftigjacques minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT preudhommeclaude minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT dombretherve minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse AT duployeznicolas minimalresidualdiseasemonitoringinacutemyeloidleukemiawithnonabdnpm1mutationsbydigitalpolymerasechainreactionfeasibilityandclinicaluse |